
    
      This study is a double-blind, placebo-controlled, single center, randomized, parallel arm
      clinical trial to test the impact of Dihydrocapsiate (placebo, 3 and 9 mg/d) ingested for 4
      weeks on resting metabolic rate and fat oxidation measured by indirect calorimetry.
    
  